Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011

Drug and Alcohol Dependence

Volumn 149, Issue , 2015, Pages 212-219

  Nielsen, S ^a,b   Roxburgh, A ^a   Bruno, R ^a,c   Lintzeris, N ^b,d   Jefferson, A ^e   Degenhardt, L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE   (Australia)

Author keywords

Codeine; Fentanyl; Oxycodone; Prescription opioid; Treatment

Indexed keywords

CODEINE; DIAMORPHINE; FENTANYL; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE;

ADULT; ARTICLE; AUSTRALIA; DRUG ABUSE PATTERN; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; NARCOTIC DEPENDENCE; PRIORITY JOURNAL; SEX RATIO; AGE; MENTAL HEALTH SERVICE; OPIOID-RELATED DISORDERS; SEX DIFFERENCE; TRENDS; YOUNG ADULT;

ADULT; AGE FACTORS; ANALGESICS, OPIOID; AUSTRALIA; FEMALE; HEROIN; HUMANS; MALE; MENTAL HEALTH SERVICES; OPIOID-RELATED DISORDERS; SEX FACTORS; YOUNG ADULT;

EID: 84926212361     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.02.004     Document Type: Article

References (47)

1. Atluri S., Sudarshan G., Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Phys. 2014, 17:E119-E128.
2. Australian Institute of Health and Welfare 2013 National Drugs Strategy Household Survey: Key Findings 2014, (accessed on 24/10/2014). http://www.aihw.gov.au/alcohol-and-other-drugs/ndshs/.
3. Australian Institute of Health and Welfare Alcohol and Other Drug Treatment Services in Australia 2012-13 2014, Drug treatment series no. 24. Cat. no. HSE 150. Canberra.
4. Australian Institute of Health and Welfare National opioid pharmacotherapy statistics 2013 2014, Drug treatment series no. 23. Cat. no. HSE 147. Canberra.
5. Brands B., Blake J., Sproule B., Gourlay D., Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004, 73:199-207.
6. Calcaterra S., Glanz J., Binswanger I.A. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013, 131:263-270.
7. Casati A., Sedefov R., Pfeiffer-Gerschel T. Misuse of medicines in the European Union: a systematic review of the literature. Eur. Addict. Res. 2012, 18:228-245.
8. Cicero T., Ellis M., Surratt H. Effect of abuse-deterrent formulation of OxyContin. N. Engl. J. Med. 2012, 367:187-189.
9. Cicero T.J., Ellis M.S., Surratt H.L., Kurtz S.P. Factors contributing to the rise of buprenorphine misuse: 2008-2013. Drug Alcohol Depend. 2014, 142:98-104.
10. Coplan P.M., Kale H., Sandstrom L., Landau C., Chilcoat H.D. Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics. Pharmacoepidemiol. Drug Saf. 2013, 22:1274-1282.
11. Day C., Conroy E., Lowe J., Page J., Dolan K. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users. Aust. J. Rural Health 2006, 14:120-125.
12. Degenhardt L., Larance B., Mathers B., Azim T., Kamarulzaman A., Mattick R., Panda S., Toufik A., Tyndall M., Wiessing L., Wodak A. Benefits and Risks of Pharmaceutical Opioids: Essential Treatment and Diverted Medication: A Global Review of Availability, Extra-Medical Use, Injection and the Association with HIV 2007, World Health Organisation, Geneva.
13. Dietze P., Jolley D., Fry C., Bammer G. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction 2005, 100:636-642.
14. Dutch M.J. Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Med. J. Aust. 2008, 188:56-57.
15. Fischer B., Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Phys. 2012, 15:ES191-ES203.
16. Fischer B., Ialomiteanu A., Boak A., Adlaf E., Rehm J., Mann R.E. Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada. Drug Alcohol Rev. 2013, 32:276-287.
17. Fischer B., Jones W., Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Pharmacoepidemiol. Drug Saf. 2013, 22:438-442.
18. Fischer B., Jones W., Urbanoski K., Skinner R., Rehm J. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011. Drug Alcohol Rev. 2013, 33:19-26.
19. Frei M., Nielsen S., Tobin C., Dobbin M. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med. J. Aust. 2010, 193:294-296.
20. Jann M., Kennedy W.K., Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J. Pharm. Pract. 2014, 27:5-16.
21. Jenkinson R.A., Clark N.C., Fry C.L., Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?. Addiction 2005, 100:197-205.
22. Kuhlman J.J., McCaulley R., Valouch T.J., Behonick G.S. Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J. Anal. Toxicol. 2003, 27:499-504.
23. Larance B., Ambekar A., Azim T., Murthy P., Panda S., Degenhardt L., Mathers B. The availability, diversion and injection of pharmaceutical opioids in South Asia. Drug Alcohol Rev. 2011, 30:246-254.
24. Layton D., Osborne V., Al-Shukri M., Shakir S.W. Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk management. Drug Saf. 2014, 37:639-650.
25. Leong M., Murnion B., Haber P.S. Examination of opioid prescribing in Australia from 1992 to 2007. Intern. Med. J. 2009, 39:676-681.
26. Lusted A., Roerecke M., Goldner E., Rehm J., Fischer B. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses. Pain Phys. 2013, 16:E671-E684.
27. Maxwell J.C. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev. 2011, 30:264-270.
28. McDonough M.A. Misuse of codeine-containing combination analgesics. Med. J Aust. 2011, 194:486.
29. Moore B.A., Fiellin D.A., Barry D.T., Sullivan L.E., Chawarski M.C., O'Connor P.G., Schottenfeld R.S. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J. Gen. Intern. Med. 2007, 22:527-530.
30. Myers B., Siegfried N., Parry C.D. Over-the-counter and prescription medicine misuse in Cape Town - findings from specialist treatment centres. S. Afr. Med. J. 2003, 93:367-370.
31. Nielsen S., Cameron J., Lee N. Characteristics of a non-treatment seeking sample of over-the-counter codeine users: implications for intervention and prevention. J. Opioid Manag. 2011, 7:363-370.
32. Nielsen S., Murnion B., Dunlop A., Degenhardt L., Demirkol A., Muhleisen P., Lintzeris N. Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series. Drug Alcohol Rev. 2014, (epub ahead of print).
33. ONCDP Epidemic Responding to America's prescription Drug Abuse Crisis 2011, Executive Office of the President of the United States.
34. Oser C.B., Harp K.L.H. Treatment outcomes for prescription drug misusers: the negative effect of geographic discordance. J. Subst. Abuse Treat. 2015, 48:77-84.
35. Passik S.D., Narayana A., Yang R. Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain. Pain Med. 2014, 15:1365-1372.
36. Patrick S.W., Schumacher R.E., Benneyworth B.D., Krans E.E., McAllister J.M., Davis M.M. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012, 307:1934-1940.
37. Pilgrim J.L., Dobbin M., Drummer O.H. Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. Med. J. Aust. 2013, 199:329-331.
38. Rintoul A.C., Dobbin M.D.H., Drummer O.H., Ozanne-Smith J. Increasing deaths involving oxycodone, Victoria, Australia, 2000-09. Inj. Prev. 2010, 17:254-259.
39. Ritter A., Di Natale R. The relationship between take-away methadone policies and methadone diversion. Drug Alcohol Rev. 2005, 24:347-352.
40. Roxburgh A., Bruno R., Larance B., Burns L. Prescription of opioid analgesics and related harms in Australia. Med. J. Aust. 2011, 195:280-284.
41. Roxburgh A., Burns L. Drug-Related Hospital Stays in Australia, 1993-2012 2013, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
42. Roxburgh A., Burns L., Drummer O.H., Pilgrim J., Farrell M., Degenhardt L. Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. Drug Alcohol Rev. 2013, 32:269-275.
43. Sees K.L., Di Marino M.E., Ruediger N.K., Sweeney C.T., Shiffman S. Non-medical use of OxyContin tablets in the United States. J. Pain. Palliat. Care Pharmacother. 2005, 19:13-23.
44. Sproule B.A.P., Busto U.E.P., Somer G.M., Romach M.K.M.D., Sellers E.M.M.D.P. Characteristics of dependent and nondependent regular users of codeine. J. Clin. Psychopharmacol. 1999, 19:367-372.
45. Stafford J., Burns L. Australian drug trends 2011. Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trend Series No 73 2012, University of New South Wales, Sydney. National Drug Alcohol Research Centre (Ed.).
46. Substance Abuse and Mental Health Services Administration Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008 2010, Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA).
47. Zech D.F., Grond S., Lynch J., Hertel D., Lehmann K.A. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995, 63:65-76.